Who
Robert F. Werner
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Twist Bioscience; Chief Accounting Officer, Invitae.
In numbers
- Trades disclosed
- 99
- Buys
- 0
- Sells
- 56
- Bought
- $0
- Sold
- $4.2M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Jun 2020
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $280K1,482 at $188.88 | filing |
| 8 Sep 2026filed 10 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $29K238 at $122.62 | filing |
| 8 Sep 2026filed 10 Sep 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $29K238 at $122.62 | filing |
| 24 Aug 2026filed 25 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $120K854 at $140.77 | filing |
| 24 Aug 2026filed 25 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $120K854 at $140.77 | filing |
| 21 Aug 2026filed 25 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $93K669 at $139.07 | filing |
| 21 Aug 2026filed 25 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $93K669 at $139.07 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $14K167 at $85.32 | filing |
| 3 Aug 2026filed 5 Aug 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $14K167 at $85.32 | filing |
| 8 Jun 2026filed 10 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $16K232 at $69.84 | filing |
| 8 Jun 2026filed 10 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $78K1,127 at $69.07 | filing |
| 8 Jun 2026filed 10 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $16K232 at $69.84 | filing |
| 8 Jun 2026filed 10 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $78K1,127 at $69.07 | filing |
| 8 Jun 2026filed 10 Jun 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Code G | —500 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $50K800 at $62.48 | filing |
| 26 May 2026filed 28 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $50K800 at $62.48 | filing |
| 21 May 2026filed 26 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $37K688 at $53.26 | filing |
| 21 May 2026filed 26 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $37K688 at $53.26 | filing |
| 8 May 2026filed 12 May 2026 | TWST Twist BioscienceGenomics & Gene Editing | SEC FORM 4 Sold | $282K4,961 at $56.88 | filing |
News
Twist Bioscience Corporation (TWST) Leads Polen's Small-Mid Growth Portfolio on Record Revenue and AI-Driven DemandTWST · insidermonkey.com · 23 Oct 2026Twist Bioscience (NASDAQ:TWST) Shares Climb 6.6% – Here's What HappenedTWST · dailypolitical.com · 23 Oct 2026Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Robert F. Werner; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.